Health Issues India

It’s been just a year since the first anti-COVID-19 vaccine surfaced. And the virus has again turned up as a complicated avatar, its fifth since the original emerged from Wuhan in China two years ago. The World Health Organization (WHO) has christened it Omicron. Since its emergence in South Africa on 24 November, cases have been identified in more than two dozen countries on every continent barring Antarctica. Omicron’s discovery has prompted considerable panic across the globe, with a number of countries banning flights from southern Africa, or — like Israel, Japan and Morocco — barring the entry of foreign travellers altogether. Much remains unknown about Omicron, including whether it is more transmissible and capable of causing more serious illness. There is some evidence the variant can reinfect people more readily, according to the authoritative science.org (www.science.org/content/article/covid-19-reinfection-study-south-africa-yields-ominous-data-about-omicron?) In … Read Full Article about Global Health Newsletter XVII